| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |